-
Harnessing Digital Measures of Physical Function in Neurological Conditions: Findings From a Targeted Literature Review
Mar 10, 2025, 14:00 PM -
All for One and One for All? Patterns of Familial Influenza Vaccination
Mar 10, 2025, 14:00 PM -
Parametric Model Selection: Beyond AIC/BIC in Health Economic Context
Mar 10, 2025, 14:00 PM -
Factors Delaying the Public Listing of New Drugs in Canada
Mar 10, 2025, 14:00 PM -
Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods
Mar 10, 2025, 14:00 PM -
Dupilumab Improves Health-Related Quality Of Life And Asthma Control In Patients With And Without Coexisting Type 2 Conditions: Results From The RAPID Study
Mar 10, 2025, 14:00 PM -
Novel Therapies for Neurofibromatosis Type 1-Associated Inoperable Plexiform Neurofibromas: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Do Lifetables Overestimate Non-Cancer-Specific Survival (NCSS) in Oncology? A Case Study From Treatment-Naïve Advanced Melanoma
Mar 10, 2025, 14:00 PM -
Assessing Stakeholder Perceptions of Product Portfolio Value Beyond Financial Benefit: Development of a Survey
Mar 10, 2025, 14:00 PM -
Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance
Mar 10, 2025, 14:00 PM -
Changes in Functional Status, Work Productivity, and Daily Activities in People With Idiopathic Hypersomnia and Narcolepsy Treated With Low-Sodium Oxybate: Results From the Phase 4 DUET Study
Mar 10, 2025, 14:00 PM -
Updated 1-Year Fracture Incidence and Costs of Fragility Fractures in US Post-Fracture Patients Based on Commercial Claims Databases
Mar 10, 2025, 14:00 PM -
Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder
Mar 10, 2025, 14:00 PM -
Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Impact of Racial and Ethnic Disparities on Health-Related Quality of Life in Older Adults With Arthritis in the United States
Mar 10, 2025, 14:00 PM -
Real-World Telehealth Utilization and Healthcare Costs in Commercially Insured Women With Breast Cancer: A Claims-Based Study
Mar 10, 2025, 14:00 PM -
Impact of Emicizumab on Quality of Life and Clinical Outcomes in Patients with Hemophilia A in Guatemala
Mar 10, 2025, 14:00 PM -
Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing
Mar 10, 2025, 14:00 PM -
Evaluating the Feasibility of a Network Meta-Analysis Comparing Treatment Options in Polycythemia Vera
Mar 10, 2025, 14:00 PM
